Literature DB >> 21856418

Sex steroid receptors in human lung diseases.

Mohit K Verma1, Yasuhiro Miki, Hironobu Sasano.   

Abstract

Several epidemiological studies have reported that gender differences exist in clinical and biological manifestations of human lung diseases. In particular, women are far more likely to develop both neoplastic and non-neoplastic lung diseases than men. This gender difference above suggests that sex steroid may be involved in the pathogenesis of various lung diseases. These sex steroids mediate their effects through sex steroid receptors including estrogen receptors (ER) i.e. ERα and ERβ progesterone receptors (PR) i.e. PR-A and PR-B and androgen receptors (ARs), all of which have been reported to be expressed in lung tissue. Therefore it becomes important to clarify the potential roles of sex steroid receptor in both neoplastic and non-neoplastic lung diseases toward improved treatment options for the patients. In this review, we summarized a number of studies in humans and experimental animals that have identified possible roles of sex steroids in respiratory physiology and pathology.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21856418     DOI: 10.1016/j.jsbmb.2011.07.013

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  18 in total

Review 1.  Endocrine regulation of lung disease and inflammation.

Authors:  Nathalie Fuentes; Patricia Silveyra
Journal:  Exp Biol Med (Maywood)       Date:  2018-12-03

2.  The role of estrogen, progesterone and aromatase in human non-small-cell lung cancer.

Authors:  Nadiyah Kazmi; Diana C Márquez-Garbán; Lilia Aivazyan; Nalo Hamilton; Edward B Garon; Lee Goodglick; Richard J Pietras
Journal:  Lung Cancer Manag       Date:  2012-12

Review 3.  Emerging concepts in smooth muscle contributions to airway structure and function: implications for health and disease.

Authors:  Y S Prakash
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-10-14       Impact factor: 5.464

Review 4.  A potential role for estrogen in cigarette smoke-induced microRNA alterations and lung cancer.

Authors:  Amit Cohen; Mario Alberto Burgos-Aceves; Yoav Smith
Journal:  Transl Lung Cancer Res       Date:  2016-06

5.  Androgen Receptor-Mediated Regulation of Intracellular Calcium in Human Airway Smooth Muscle Cells.

Authors:  Rama Satyanarayana Raju Kalidhindi; Rathnavali Katragadda; Kerri L Beauchamp; Christina M Pabelick; Y S Prakash; Venkatachalem Sathish
Journal:  Cell Physiol Biochem       Date:  2019

Review 6.  Women and Lung Disease. Sex Differences and Global Health Disparities.

Authors:  Kent E Pinkerton; Mary Harbaugh; MeiLan K Han; Claude Jourdan Le Saux; Laura S Van Winkle; William J Martin; Rose J Kosgei; E Jane Carter; Nicole Sitkin; Suzette M Smiley-Jewell; Maureen George
Journal:  Am J Respir Crit Care Med       Date:  2015-07-01       Impact factor: 21.405

7.  The role of personal attributes in the genesis and progression of lung disease and cigarette smoking.

Authors:  Adam Brook; Chenshu Zhang
Journal:  Am J Public Health       Date:  2012-09-20       Impact factor: 9.308

Review 8.  Airway smooth muscle in airway reactivity and remodeling: what have we learned?

Authors:  Y S Prakash
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-10-18       Impact factor: 5.464

9.  17β-estradiol replacement reverses age-related lung disease in estrogen-deficient C57BL/6J mice.

Authors:  Marilyn K Glassberg; Rhea Choi; Vita Manzoli; Shahriar Shahzeidi; Peter Rauschkolb; Robert Voswinckel; Muddassir Aliniazee; Xiaomei Xia; Sharon J Elliot
Journal:  Endocrinology       Date:  2013-11-25       Impact factor: 4.736

10.  Androgen receptor activation alleviates airway hyperresponsiveness, inflammation, and remodeling in a murine model of asthma.

Authors:  Rama Satyanarayana Raju Kalidhindi; Nilesh Sudhakar Ambhore; Premanand Balraj; Taylor Schmidt; M Nadeem Khan; Venkatachalem Sathish
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-03-10       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.